Celsius Therapeutics
Biotechnology ResearchMassachusetts, United States2-10 Employees
Celsius Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on developing precision medicines for cancer and autoimmune diseases. It relies on detailed cellular and genomic data to guide drug discovery and development, translating complex biology into therapeutic candidates. The organization emphasizes an open, collaborative culture and seeks to attract and retain talent determined to advance its mission. Operating within the biotechnology research sector, the company frames its work around scalable human biology insights to identify and de-risk potential therapies. In August 2022, Celsius Therapeutics appointed Sarah Grant as chief medical officer, reflecting leadership changes in its recent history.